Integration of radiobiological modeling with clinical outcomes for optimizing carotid-sparing treatment planning in head and neck cancers.

Authors

Mohsin R Khan, Malik Tariq Rasool, Malik Mohib-Ul Haq

Published in

Journal of cancer research and therapeutics. Volume 22. Issue 5. Pages 842-847. Jul 01, 2026. Epub Oct 29, 2026.

Abstract

Radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC) can deliver significant incidental doses to the carotid arteries, increasing the risk of late vascular events. Carotid-sparing intensity-modulated radiotherapy (IMRT) with radiobiological modelling may reduce these risks without compromising tumour control.
To assess the predictive accuracy of normal tissue complication probability (NTCP) modelling for carotid stenosis and its association with tumour control, vascular events, and quality of life in HNSCC patients treated with carotid-sparing IMRT.
In this prospective observational study, 120 patients with HNSCC underwent carotid-sparing IMRT. Dose-volume histograms were used to calculate NTCP for carotid stenosis using the Lyman-Kutcher-Burman model, and tumour control probability (TCP) from target coverage. Patients were followed for ≥5 years with Doppler ultrasonography, MRI angiography when indicated, neurocognitive testing, and EORTC QLQ-H and N35 questionnaires. The primary endpoint was correlation between NTCP and ≥50% radiographically confirmed carotid stenosis. Kaplan-Meier, Cox regression, and ROC analyses were performed.
At 5 years, high NTCP (>8%) was associated with reduced stenosis-free survival compared to low NTCP (≤5%) (HR = 5.62; 95% CI: 2.1-14.8; P < 0.001). NTCP correlated with incidence of ≥50% stenosis ( r = 0.78; P < 0.001) and cerebrovascular events ( P = 0.002). ROC analysis demonstrated good predictive accuracy (AUC = 0.84). TCP remained >90% across all NTCP quartiles. Low NTCP was associated with slower intima-media thickness progression and better neurocognitive and quality-of-life scores.
NTCP modelling reliably predicts late carotid stenosis and vascular outcomes in HNSCC patients receiving IMRT and supports patient-specific carotid-sparing strategies.

PMID:
42955964
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.